Thermogenesis Holdings Executives
THMODelisted Stock | USD 0.32 0.01 3.03% |
Thermogenesis Holdings employs about 25 people. The company is managed by 4 executives with a total tenure of roughly 59 years, averaging almost 14.0 years of service per executive, having 6.25 employees per reported executive. Analysis of Thermogenesis Holdings' management performance can provide insight into the firm performance.
Thermogenesis |
Thermogenesis Holdings Management Team Effectiveness
The company has return on total asset (ROA) of (0.255) % which means that it has lost $0.255 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.0194) %, meaning that it created substantial loss on money invested by shareholders. Thermogenesis Holdings' management efficiency ratios could be used to measure how well Thermogenesis Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Thermogenesis Holdings Workforce Comparison
Thermogenesis Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 622. Thermogenesis Holdings holds roughly 25.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.2. Thermogenesis Holdings Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Thermogenesis Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Thermogenesis Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Thermogenesis Holdings insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Haihong Zhu over six months ago Disposition of 5000 shares by Haihong Zhu of Thermogenesis Holdings at 30.0 subject to Rule 16b-3 | ||
Xu Xiaochun over six months ago Disposition of tradable shares by Xu Xiaochun of Thermogenesis Holdings at 0.38 subject to Rule 16b-3 | ||
Xu Xiaochun over a year ago Sale by Xu Xiaochun of 600000 shares of Thermogenesis Holdings | ||
Xu Xiaochun over a year ago Conversion by Xu Xiaochun of 654206 shares of Thermogenesis Holdings | ||
Stracey Robin C over a year ago Acquisition by Stracey Robin C of 15000 shares of Thermogenesis Holdings subject to Rule 16b-3 | ||
Xu Xiaochun over a year ago Conversion by Xu Xiaochun of tradable shares of Thermogenesis Holdings |
Thermogenesis Holdings Notable Stakeholders
A Thermogenesis Holdings stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Thermogenesis Holdings often face trade-offs trying to please all of them. Thermogenesis Holdings' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Thermogenesis Holdings' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Haihong Zhu | Chief Officer | Profile | |
Jeffery CPA | Principal CFO | Profile | |
Xiaochun MBA | Chairman CEO | Profile | |
Mindy WilkeDouglas | VP Operations | Profile |
About Thermogenesis Holdings Management Performance
The success or failure of an entity such as Thermogenesis Holdings often depends on how effective the management is. Thermogenesis Holdings management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Thermogenesis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Thermogenesis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor and other cell-based therapies. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. Thermogenesis Holdings operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs people.
Thermogenesis Holdings Workforce Analysis
Traditionally, organizations such as Thermogenesis Holdings use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Thermogenesis Holdings within its industry.Thermogenesis Holdings Manpower Efficiency
Return on Thermogenesis Holdings Manpower
Revenue Per Employee | 377.8K | |
Revenue Per Executive | 2.4M | |
Net Loss Per Employee | 756.8K | |
Net Loss Per Executive | 4.7M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Thermogenesis Stock
If you are still planning to invest in Thermogenesis Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thermogenesis Holdings' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Stocks Directory Find actively traded stocks across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |